表紙:e薬局市場 - 2020年から2025年までの予測
市場調査レポート
商品コード
1002818

e薬局市場 - 2020年から2025年までの予測

E-Pharmacy Market - Forecasts from 2020 to 2025

出版日: | 発行: Knowledge Sourcing Intelligence | ページ情報: 英文 131 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
e薬局市場 - 2020年から2025年までの予測
出版日: 2020年11月12日
発行: Knowledge Sourcing Intelligence
ページ情報: 英文 131 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

e薬局市場は、2019年の298億2,971万4,000米ドルから、2025年には1,175億24万7,000米ドルへ、25.67%のCAGRで成長すると予測されています。世界経済が新型コロナウイルス感染症(COVID-19)の世界的大流行の嵐を乗り切ろうとしている中、いくつかの国では驚くべき数の死者がでています。世界的な慢性疾患の増加や、感染症の発生、高齢者の増加などを背景に、近い将来、薬物療法のニーズが高まることが明らかになっています。また、不健康な食生活や飲酒・喫煙などによって疾患の罹患率はさらに上昇すると考えられることから、e薬局市場は予測期間中、そしてそれ以降も成長する見通しがされています。

当レポートでは、世界のe薬局市場を調査し、市場の概要、医薬品タイプ・分野・地域別の市場規模の推移と予測、市場の促進要因および抑制要因の分析、ファイブフォース分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

  • 市場の定義
  • 市場セグメンテーション

第2章 調査手法

  • 調査データ
  • 仮定

第3章 エグゼクティブサマリー

  • 調査のハイライト

第4章 市場力学

  • 市場の推進要因
  • 市場の抑制要因
  • ファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 競争企業間の敵対関係
    • 新規参入企業の脅威
    • 代替品の脅威
  • バリューチェーン分析

第5章 e薬局市場の分析:医薬品タイプ別

  • イントロダクション
  • 一般用医薬品(OTC)
  • 医療用医薬品

第6章 e薬局市場の分析:分野別

  • イントロダクション
  • 風邪・インフルエンザ
  • 歯科
  • 皮膚科
  • 栄養
  • 体重管理
  • その他

第7章 e薬局市場の分析:地域別

  • イントロダクション
  • 北米
    • タイプ別
    • 用途別
    • 国別
  • 南米
    • タイプ別
    • 用途別
    • 国別
  • 欧州
    • タイプ別
    • 用途別
    • 国別
  • 中東・アフリカ
    • タイプ別
    • 用途別
    • 国別
  • アジア太平洋地域
    • タイプ別
    • 用途別
    • 国別

第8章 競合環境と分析

  • 主要企業と戦略分析
  • 新興企業と市場の収益性
  • 合併・買収・合意・コラボレーション
  • ベンダーの競争力マトリックス

第9章 企業プロファイル

  • 1mg
  • Canada Health Infoway
  • DocMorris
  • Express Scripts Holding Company
  • Giant Eagle, Inc.
  • The Kroger Co.
  • Netmeds Marketplace Ltd.
  • OptumRx, Inc.
  • Rowlands Pharmacy
  • Walgreen Co.
  • WalmartKemin Industries, Inc.
目次

The e-pharmacy market is projected to grow at a CAGR of 25.67% to reach US$117,500.247 million by 2025 from US$29,829.714 million in 2019. As the global economy prepares to weather the storm of the current global pandemic called CoVid19 where a few nations registered an alarming number of demises at this day and age, it is stark confirmation that global burden of chronic disease, the incidence of infection and an expanding geriatric patient pool require prophylactic and therapeutic services that will further increase in the near future consequently increasing the need for medication therapy. Moreover, the increasing adherence to unhealthy diet, behavioral risks like drinking and smoking among the majority of the population will lead to a further rise in disease prevalence that is poised to drive the E-Pharma Market. Moreover, due to the ubiquitous nature of the internet and ongoing market penetration that has resulted in the global netizens and with the numbers rising the e-pharma market is further poised to grow during the forecast period and beyond.

Moreover, stringent policy measures to uphold transparency in a pharmaceutical business transaction is expected to further catapult the E-Pharma Market. Moreover, the growing realization of prospects in this space is giving way for investments like that of US$ 7.2 million by a Korean investment firm Redwood Global Healthcare Fund in Gurugram (India) based 1mg Technologies Pvt. Ltd. Besides the prevalence of disruption in almost every industry is also another factor that is poised to drive the e-pharma market as a means to supplant an outdated system that adds to the woes of a patient. To this end, in March 2020 an online pharmacy and prescriber called e-Surgery were established in the UK with an objective to reduce greenhouse gas emissions and curve an ecosystem that will support the electronic prescriptions that are already in effect in the UK. The primary reason is to enable patients to access prescription medication for common conditions without having to see their doctors. With this option, the medication gets delivered to the patients 100% recyclable and biodegradable packaging after going through a few steps. Thus, growing investment in and innovation in the online pharmacy space will throttle the expansion of e-pharma market over the coming period. However, stringent and changing regulatory policies may impede e-pharmacy industry growth to a certain extent over the forecast periods.

The segment that is expected to fuel the growth of the e-Pharma Market is Over-the-drugs (OTC) drug category. Due to the fact that no prescription is required and along with the convenience that the e-Pharma facility extends, customer adoption will rise and become a growing customer preference. Further, the various products that come under the ambit of dermatology too will push the E-Pharma Market to a new echelon during the forecast period. This is due to the growing preference and demand for cosmetic and aesthetic products. To facilitate such a trend and to set new ones in the E-Pharma Market a Singapore based Singapore-based health-tech startup Gmedes has developed the G-Meds app to enable doctors, clinics, and hospitals to prescribe, bill, and deliver medicines to their patients. The app handles both the front- and the back-end compliant processes, which are inclusive of but not limited to, delivery, customs clearing, logistics tracking, and import taxes. It plans to use the new funds to establish partnerships to implement the G-Meds service for medical institutions across Singapore, Indonesia, China, Malaysia, the Philippines, and Indochina. With South East Asia becoming a major global tourism hub the time just apt for the rollout of such a service. It serves areas like cardiology, respiratory, arthritis, and rheumatoid arthritis, dermatology, and mental health.

From a national perspective, Estonia is one of the first to launch a countrywide e-prescription system that was initiated by the Estonian Health Insurance Fund, which witnessed an 84% of prescriptions being issued digitally. In Estonia, the e-prescription system provides an overview of all prescriptions issued for a patient and with this information, it is possible to evaluate any interactions between pharmaceuticals prescribed by different doctors. 2020, marks the 10th anniversary of the e-prescription service. Thus, with nations making it a policy imperative to steer its citizens to adopt the e-Pharma facility is another aspect that will drive the growth of the e-Pharma market during the forecast period. Further, a large patient pool is nearing old age or is already old along with chronically ill patients, the e-Pharmacies reduces the dependency on others to procure medicine and healthcare supplies. The plethora of benefits that e-Pharma has to offer is also enthusing large corporations as exemplified by Amazon's foray into this space with the acquisition of PillPack, a small Boston based company that had obtained a license to sell prescription drugs in all US states, and was a digital service from the very commencement of its operations. This was also advantageous for Amazon since it could evade all sots of legislative difficulties involved in the sale of prescription drugs.

Segmentation

By Drug Types

  • Over-the-counter (OTC) drugs
  • Prescription drugs

By Application

  • Cold and flu
  • Dental
  • Dermatology
  • Nutrition
  • Weight management
  • Others

By Geography

  • North America

USA

Canada

Mexico

  • South America

Brazil

Argentina

Others

  • Europe

UK

Germany

France

Others

  • The Middle East and Africa

Saudi Arabia

UAE

Israel

Others

  • Asia Pacific

Japan

China

India

Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. E-Pharmacy Market Analysis, By Drug Types

  • 5.1. Introduction
  • 5.2. Over-the-counter (OTC) drugs
  • 5.3. Prescription drugs

6. E-Pharmacy Market Analysis, By Therapeutic Area

  • 6.1. Introduction
  • 6.2. Cold and flu
  • 6.3. Dental
  • 6.4. Dermatology
  • 6.5. Nutrition
  • 6.6. Weight management
  • 6.7. Others

7. E-Pharmacy Market Analysis, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. North America E-Pharmacy Market Analysis, By Types
    • 7.2.2. North America E-Pharmacy Market Analysis, By Application
    • 7.2.3. By Country
      • 7.2.3.1. United States
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. South America E-Pharmacy Market Analysis, By Types
    • 7.3.2. South America E-Pharmacy Market Analysis, By Application
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. Europe E-Pharmacy Market Analysis, By Types
    • 7.4.2. Europe E-Pharmacy Market Analysis, By Application
    • 7.4.3. By Country
      • 7.4.3.1. UK
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Middle East and Africa E-Pharmacy Market Analysis, By Types
    • 7.5.2. Middle East and Africa E-Pharmacy Market Analysis, By Application
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. United Arab Emirates
      • 7.5.3.3. Israel
      • 7.5.3.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific E-Pharmacy Market Analysis, By Types
    • 7.6.2. Asia Pacific E-Pharmacy Market Analysis, By Application
    • 7.6.3. By Country
      • 7.6.3.1. Japan
      • 7.6.3.2. China
      • 7.6.3.3. India
      • 7.6.3.4. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles

  • 9.1. 1mg
  • 9.2. Canada Health Infoway
  • 9.3. DocMorris
  • 9.4. Express Scripts Holding Company
  • 9.5. Giant Eagle, Inc.
  • 9.6. The Kroger Co.
  • 9.7. Netmeds Marketplace Ltd.
  • 9.8. OptumRx, Inc.
  • 9.9. Rowlands Pharmacy
  • 9.10. Walgreen Co.
  • 9.11. WalmartKemin Industries, Inc.